Abstract
EVALUATION OF ANTIHYPERLIPEDEMIC ACTIVITY OF VARIOUS EXTRACTS OF BEET ROOT (BETA VULGARIS)

Dr. Mukuntha Kumar N.* and Asish Bhaumik

ABSTRACT

Hyperlipidemia is abnormally elevated levels of any or all lipids and/or lipoproteins in the blood. It is the most common form of dyslipidemia (which includes any abnormal lipid levels). Lipids (water-insoluble molecules) are transported in a protein capsule. The size of that capsule, or lipoprotein, determines its density. The lipoprotein density and type of apolipoproteins it contains determines the fate of the particle and its influence on metabolism. Hyperlipidemias are divided into primary and secondary subtypes. Primary hyperlipidemia is usually due to genetic causes (such as a mutation in a receptor protein), while secondary hyperlipidemia arises due to other underlying causes such as diabetes. Lipid and lipoprotein abnormalities are common in the general population and are regarded as a modifiable risk factor for cardiovascular disease due to their influence on atherosclerosis. In addition, some forms may predispose to acute pancreatitis. The main aim and objective of my present research work was the preliminary phytochemical screening of various extracts of beet root (Beta vulgaris, EEBT, MEBT and CEBT) and evaluation of antihyperlipedemic activity. The experimental data was displayed that the various extracts such EEBT, MEBT and CEBT were showing the lipid lowering ability in experimental rats with reference to standard drug lovastatin. The decreased serum lipids profile by various extracts such as EEBT, MEBT and CEBT were found to be 77.24, 73.22 and 78.11 mg/dl (total cholesterol i, e TCH), 110.34, 98.54 and 119.31 mg/dl (TGS), 21.32, 21.74 and 21.31 mg/dl (HDL-C), 32.52, 29.21, and 34.30 mg/dl (LDL-C) and 18.32, 21.32 and 23.11 mg/dl (VLDL-C) etc.

Keywords: Hyperlipidemia, lipoproteins, diabetes, atherosclerosis, antihyperlipedemic etc.


[Full Text Article]

Login





Forgot Password  |  Register

Indexing

Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Dr. Dhrubo Jyoti Sen

Download Article : Click here

News & Updation

  • EJBPS: MAY ISSUE PUBLISHED

    MAY 2022 Issue has been successfully launched on 1 May 2022.

  • EJBPS New Impact Factor

    Its our Pleasure to Inform you that EJBPS Impact Factor has been increased from 5.467 to 6.044, due to high quality Publication at International Level.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.

     

UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS

Downloads

Copyright From

Covering Letter

                        Author Instruction 
 

PLAGERLUM REPORT